| Bid Price | 3.70p | High Price | 3.89p |
|---|
| Ask Price | 3.90p | Low Price | 3.72p |
|---|
| Open Price | 3.80p | Spread | 5.13% |
|---|
| Prev Close | 3.80p | Volume | 100,102 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 17, 2024 | 3.80 | 3.89 | 3.72 | 3.80 | 163,284 |
| Apr 16, 2024 | 3.90 | 3.89 | 3.72 | 3.80 | 1,362,731 |
| Apr 15, 2024 | 4.30 | 4.38 | 3.80 | 3.90 | 2,975,946 |
| Apr 12, 2024 | 3.95 | 4.19 | 4.00 | 4.05 | 1,652,389 |
| Apr 11, 2024 | 4.20 | 4.30 | 3.86 | 3.90 | 1,540,707 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 5,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 95.37 m | Prev Close | 3.80p |
|---|
| PE Ratio | | Market Cap | £3.71 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -1.004849 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.263538 | Quick Ratio | 1.729242 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/12/23 | BUY | Simon Douglas | CH | 100,565 @ £0.05 | £4,988.00 |
| 04/12/23 | BUY | Adrian Kinkaid | CEO | 101,847 @ £0.05 | £4,991.00 |
| 12/06/23 | BUY | Richard Buick | ED | 68,750 @ £0.07 | £4,950.00 |
| 24/05/23 | PLAC | Colin Walsh | NED | 600,000 @ £0.05 | £30,000.00 |
| 24/05/23 | PLAC | Simon Douglas | CH | 200,000 @ £0.05 | £10,000.00 |
Fusion Antibodies PLC News
